Inventor · disambiguated record
Paul Loadman
Also filed as: LOADMAN PAUL · LOADMAN PAUL MICHAEL
8 granted patents·4 pending applications·19 citations·filing 2002–2020
83Inventor score
Top patents by PatentIndex Score
12 records- 0180US9358303B2Compounds containing a vascular disrupting agentINCANTHERA LTD·Filed 2013·Granted Jun 7, 2016·5 cites·17 claims
- 0277US9956296B2Compounds containing a vascular disrupting agentINCANTHERA LTD·Filed 2016·Granted May 1, 2018·2 cites·18 claims
- 0377US8691751B2Compounds containing a vascular disrupting agentGILL JASON·Filed 2008·Granted Apr 8, 2014·6 cites·21 claims
- 0476US8927486B2CompoundsFALCONER ROBERT·Filed 2009·Granted Jan 6, 2015·4 cites·24 claims
- 0573US10201622B2Tumour-targeted theranosticUNIV BRADFORD·Filed 2014·Granted Feb 12, 2019·1 cites·18 claims
- 0672US9937267B2Methods of treating cancer using compounds containing a vascular disrupting agentINCANTHERA LTD·Filed 2016·Granted Apr 10, 2018·1 cites·28 claims
- 0766US2020316212A1Methods of treating cancer using compounds containing a vascular disrupting agentELLIPSES PHARMA LTD·Filed 2020·Application pending·0 cites
- 0863US10912839B2Methods of treating cancer using compounds containing a vascular disrupting agentELLIPSES PHARMA LTD·Filed 2018·Granted Feb 9, 2021·0 cites·25 claims
- 0960US10556014B2Compounds containing a vascular disrupting agentINCANTHERA LTD·Filed 2018·Granted Feb 11, 2020·0 cites·24 claims
- 1060US2015196658A1CompoundsINCANTHERA LTD·Filed 2014·Application pending·0 cites
- 1134US2019015519A1Mmp-sensitive taxane prodrugINCANTHERA LTD·Filed 2016·Application pending·0 cites
- 1232US2004248765A1Tumour targeting prodrugs activated by metallo matrixproteinasesFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →